Jaguar Animal Health (JAGX) has issued an announcement.
Jaguar Health, Inc. stockholders approved all four proposals during a special meeting on April 9, 2024, including a reverse stock split to meet Nasdaq’s minimum bid price requirement and the issuance of common stock upon the exchange of Series J Preferred Stock. The company had previously received a delisting warning from Nasdaq due to its stock price falling below $1.00, and a subsequent delisting determination letter when the bid price dropped to $0.10. Jaguar Health has been granted an extension until August 13, 2024, to regain compliance with Nasdaq’s listing rules.
See more insights into JAGX stock on TipRanks’ Stock Analysis page.
